Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-037792
Filing Date
2019-10-24
Accepted
2019-10-24 19:40:44
Documents
46
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20190930.htm 10-Q 1220103
2 EX-31.1 mnov-ex311_9.htm EX-31.1 11013
3 EX-31.2 mnov-ex312_8.htm EX-31.2 10915
4 EX-32.1 mnov-ex321_7.htm EX-32.1 7886
5 EX-32.2 mnov-ex322_6.htm EX-32.2 7812
  Complete submission text file 0001564590-19-037792.txt   3571531

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20190930.xml EX-101.INS 563112
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20190930.xsd EX-101.SCH 28729
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20190930_cal.xml EX-101.CAL 31870
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20190930_def.xml EX-101.DEF 84376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20190930_lab.xml EX-101.LAB 255520
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20190930_pre.xml EX-101.PRE 188626
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 191167139
SIC: 2834 Pharmaceutical Preparations